Clonal analysis of immunoglobulin mRNA in rheumatoid arthritis synovium: Characterization of expanded IgG3 populations

European Journal of Immunology - Tập 27 Số 2 - Trang 476-485 - 1997
David G. Williams1, Peter C. Taylor1
1The Kennedy Institute, London, GB

Tóm tắt

Abstract

Plasma cells secreting IgG, M, and A abound in the synovium of patients with rheumatoid arthritis, yet their immunoglobulin repertoire and clonal relationship remain to be elucidated. Locally synthesized immunoglobulins probably contribute to the chronic joint inflammatory processes which are characteristic of these patients. To determine whether B lymphocyte proliferation contributes to the synovial plasma cell infiltrate, the clonality of IgG mRNA in individual synovial biopsies from an actively inflamed joint of patients with rheumatoid arthritis was investigated by a combination of cDNA length analysis and DNA sequencing. Particular sizes of immunoglobulin cDNA, detectable in subclasses 1, 3, or 4, were expressed in most synovial biopsies from one patient, suggesting their origin from expanded clones present in each biopsy. To prove a clonal relationship between recurrent cDNA lengths, immunoglobulin cDNA was cloned from three regions of synovium in three patients. The sequence of clones with a recurrent cDNA length was determined. An IgG3 clone found in most synovial biopsies of one patient was encoded by an unmutated copy of the VH1 gene, DP7. In contrast, IgG3 clones encoded by mutated versions of the VH3 gene DP49 or the VH4 gene DP63 were expanded in the other two patients. Different somatic mutants of these clones were isolated from different sites in these patients. The ratio of replacement/silent somatic mutations in these two families of clones suggests that the selective clonal expansion in the synovium of patients with rheumatoid arthritis is due to an antigen‐driven immune response.

Từ khóa


Tài liệu tham khảo

10.1111/j.1365-3083.1995.tb03600.x

10.1172/JCI105758

10.1002/art.1780280704

10.1002/art.1780251210

Munthe E., 1972, Clin. Exp. Immunol., 12, 55

10.1002/art.1780301215

10.1002/art.1780370707

Ziff M., 1990, J. Rheumatol., 17, 127

10.1111/j.1365-2249.1992.tb06937.x

Natvig J. B., 1990, Clin. Exp. Rheumatol., 8, 75

10.1172/JCI114841

10.1016/0090-1229(85)90095-9

10.1002/art.1780310302

10.1016/0003-2697(87)90021-2

10.1016/S1046-2023(05)80212-9

10.1016/0022-2836(92)90223-7

10.1016/0092-8674(81)90400-1

10.1084/jem.173.2.395

Nakamura M., 1990, Nippon Seikeigeka Gakkai Zasshi, 64, 798

10.1172/JCI116968

10.1002/eji.1830251010

10.1111/j.1365-3083.1995.tb03596.x

Kristiansen S. V., 1994, J. Immunol., 153, 2974, 10.4049/jimmunol.153.7.2974

10.1111/j.1365-3083.1991.tb02492.x

Tzioufas A. G., 1990, Clin. Exp. Rheumatol., 8, 17

Van Der Harst D., 1990, Blood, 76, 2321, 10.1182/blood.V76.11.2321.2321

Brown C. M., 1995, Immunology, 84, 367

10.1172/JCI117265

10.1007/BF00541279

10.1111/j.1365-3083.1994.tb03350.x

Huang C., 1993, J. Immunol., 151, 5290, 10.4049/jimmunol.151.10.5290

10.1172/JCI116514

10.1016/S0065-2776(08)60774-9

Pelton B. K., 1985, Clin. Exp. Immunol., 62, 657

10.1002/art.1780350108

10.1006/clin.1993.1144

10.1172/JCI110424

10.3109/08916939408995695